Dual-action GLP-1/GIP Receptor Agonist Unleash next-gen fat loss with GLP2, a powerful incretin mimetic that targets both GLP-1 and GIP receptors to suppress appetite, enhance insulin sensitivity, and accelerate metabolic rate. Clinically shown to deliver dramatic weight reduction, GLP2 supports improved glucose control and long-term fat-burning potential—ideal for clients on a structured transformation journey.